clinical trial · NCT00648271
Fed Study of Metoprolol Tartrate Tablets 25 mg and Lopressor® 50 mg
HealthyMetoprolol Tartrate Tablets 25 mgLopressor® Tablets 50 mg
brief summary
The objective of this study was to investigate the bioequivalence of Mylan's metoprolol tartrate tablets to Novartis' Lopressor® tablets following a single, oral 50 mg (2 x 25 mg tablets for Mylan's formulation and 1 x 50 mg for Lopressor®) dose administered under fed conditions.
started
Dec 1, 2002
primary completion
Dec 1, 2002
completion
Jan 1, 2003
last updated
Apr 23, 2024
official title
Single-Dose Food In Vivo Bioequivalence Study of Metoprolol Tartrate Tablets (25 mg; Mylan) and Lopressor® (50 mg; Novartis) in Healthy Volunteers
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol